Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Revenue: 2020-2022

Historic Revenue for Immuneering (IMRX) over the last 3 years, with Dec 2022 value amounting to $316,952.

  • Immuneering's Revenue fell 99.76% to $455 in Q4 2022 from the same period last year, while for Dec 2022 it was $316,952, marking a year-over-year decrease of 84.76%. This contributed to the annual value of $316,952 for FY2022, which is 84.76% down from last year.
  • As of FY2022, Immuneering's Revenue stood at $316,952, which was down 84.76% from $2.1 million recorded in FY2021.
  • Over the past 5 years, Immuneering's Revenue peaked at $2.3 million during FY2020, and registered a low of $316,952 during FY2022.
  • Its 3-year average for Revenue is $1.6 million, with a median of $2.1 million in 2021.
  • Data for Immuneering's Revenue shows a maximum YoY slumped of 84.76% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Immuneering's Revenue stood at $2.3 million in 2020, then dropped by 10.02% to $2.1 million in 2021, then slumped by 84.76% to $316,952 in 2022.